This section provides links to policies related to requirements for expedited adverse event reporting, emergency unblinding, and the monitoring of study progress for safety in DAIDS-supported clinical research that fall within the scope of the policy.
-
POL-A15-OPC-00600-DAIDS-Emergency-Unblinding-Policy-Final.pdf (222.78 KB) -
eaereportpolicy.pdf (258.1 KB) -
StudyProgressSafetyMonitoringPolicy.pdf (305.98 KB)